Australia markets open in 4 hours 46 minutes

Universe Pharmaceuticals INC (UPC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.1400-0.0400 (-1.83%)
As of 01:06PM EST. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 549.59M
Enterprise value 316.34M
Trailing P/E 5.15
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)1.28
Price/book (mrq)0.98
Enterprise value/revenue 30.42
Enterprise value/EBITDA 71.19

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-54.53%
S&P500 52-week change 324.47%
52-week high 311.9900
52-week low 32.1000
50-day moving average 32.3530
200-day moving average 32.9117

Share statistics

Avg vol (3-month) 3188.37k
Avg vol (10-day) 3147.07k
Shares outstanding 521.75M
Implied shares outstanding 6N/A
Float 87.08M
% held by insiders 167.46%
% held by institutions 11.61%
Shares short (14 Nov 2021) 438.77k
Short ratio (14 Nov 2021) 40.31
Short % of float (14 Nov 2021) 40.42%
Short % of shares outstanding (14 Nov 2021) 40.18%
Shares short (prior month 14 Oct 2021) 438.76k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 29 Sept 2020
Most-recent quarter (mrq)30 Mar 2021


Profit margin 24.95%
Operating margin (ttm)34.33%

Management effectiveness

Return on assets (ttm)17.61%
Return on equity (ttm)28.26%

Income statement

Revenue (ttm)38.61M
Revenue per share (ttm)2.40
Quarterly revenue growth (yoy)48.20%
Gross profit (ttm)14.09M
Net income avi to common (ttm)9.63M
Diluted EPS (ttm)0.5990
Quarterly earnings growth (yoy)40.90%

Balance sheet

Total cash (mrq)36M
Total cash per share (mrq)1.65
Total debt (mrq)2.75M
Total debt/equity (mrq)5.41
Current ratio (mrq)3.73
Book value per share (mrq)2.33

Cash flow statement

Operating cash flow (ttm)-1.21M
Levered free cash flow (ttm)-645.13k